Shares of Biogen Inc.
gained about 1.7% in premarket trading on Wednesday after the company beat revenue and earnings expectations in the fourth quarter. Biogen had earnings of $550.4 million, or $3.79 per share, in the fourth quarter, up from $368.2 million, or $2.50 per share, in the same three months of 2021. Adjusted earnings per share were $4.05, against a FactSet consensus of $3.49. The company’s revenue came in at $2.5 billion for the quarter, down from $2.
gained about 1.7% in premarket trading on Wednesday after the company beat revenue and earnings expectations in the fourth quarter. Biogen had earnings of $550.4 million, or $3.79 per share, in the fourth quarter, up from $368.2 million, or $2.50 per share, in the same three months of 2021. Adjusted earnings per share were $4.05, against a FactSet consensus of $3.49. The company’s revenue came in at $2.5 billion for the quarter, down from $2.